CA2228251A1 - Systeme d'administration de medicaments a base de chitosan - Google Patents

Systeme d'administration de medicaments a base de chitosan Download PDF

Info

Publication number
CA2228251A1
CA2228251A1 CA 2228251 CA2228251A CA2228251A1 CA 2228251 A1 CA2228251 A1 CA 2228251A1 CA 2228251 CA2228251 CA 2228251 CA 2228251 A CA2228251 A CA 2228251A CA 2228251 A1 CA2228251 A1 CA 2228251A1
Authority
CA
Canada
Prior art keywords
chitosan
drug
composition
oral
progesterone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2228251
Other languages
English (en)
Inventor
Kuang T. Hsu
Gurpreet Singh
Joseph S. Podolski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Zonagen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zonagen Inc filed Critical Zonagen Inc
Publication of CA2228251A1 publication Critical patent/CA2228251A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention porte d'une manière générale sur une nouvelle composition pour l'administration de médicaments et plus spécifiquement sur une composition pour l'administration de médicaments consistant en particules de fer/chitosan combinées au médicament désiré, à un composé du médicament préparé avec du chitosan, ou à une composition de chitosan/huile-tensioactif et de la substance désirée. Elle porte en outre sur un système d'administration de médicaments recourant à ces compositions et sur des procédés d'élaboration de ces compositions.
CA 2228251 1996-06-11 1997-06-11 Systeme d'administration de medicaments a base de chitosan Abandoned CA2228251A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1954396P 1996-06-11 1996-06-11
US60/019,543 1996-06-11

Publications (1)

Publication Number Publication Date
CA2228251A1 true CA2228251A1 (fr) 1997-12-18

Family

ID=21793774

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2228251 Abandoned CA2228251A1 (fr) 1996-06-11 1997-06-11 Systeme d'administration de medicaments a base de chitosan

Country Status (6)

Country Link
EP (1) EP0843559A2 (fr)
JP (1) JPH10513202A (fr)
CN (1) CN1198100A (fr)
AU (1) AU3481497A (fr)
CA (1) CA2228251A1 (fr)
WO (1) WO1997047323A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19940794A1 (de) * 1999-08-27 2001-03-01 Lohmann Therapie Syst Lts Pharmazeutische Zubereitung
FR2854072B1 (fr) * 2003-04-23 2006-08-04 Centre Nat Rech Scient Vecteur pour administration par voie orale
US7588774B2 (en) 2003-05-12 2009-09-15 Becton, Dickinson And Company Molecules enhancing dermal delivery of influenza vaccines
JP5080474B2 (ja) * 2005-09-15 2012-11-21 カウンスィル オブ サイエンティフィック アンド インダストリアル リサーチ タンパク質／ペプチドの経口送達のためのｐＨ感受性ナノ粒子製剤
EP1797870A1 (fr) * 2005-12-14 2007-06-20 The Jordanian Pharmaceutical Manufacturing Co. Application orale des protéines comme microémulsion
EP2042166A1 (fr) * 2007-09-25 2009-04-01 The Jordanian Pharmaceutical Manufacturing Co. Nanocapsules pour l'administration orale de protéines
US9161901B2 (en) 2008-02-21 2015-10-20 University Of South Florida Nanoparticle targeted drug delivery to the lungs using extra-testicular Sertoli cells
WO2013152314A1 (fr) * 2012-04-06 2013-10-10 University Of North Texas Procédé simple pour fabriquer des compositions biomédicales non toxiques comprenant des microparticules hybrides métal-polymère
CN112999198A (zh) * 2021-03-10 2021-06-22 中农宠物营养研究院(江苏)有限公司 基于壳聚糖-Fe包衣的能耐胃酸并肠道靶向释放的合生素微胶囊及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0240242B2 (ja) * 1985-03-14 1990-09-11 Etaburisuman Ekusukontooru Daiichitetsuionhaiisakutaijonokitosanjudotairui
IT1184161B (it) * 1985-03-14 1987-10-22 Franco Conti Derivati del chitosano costituiti da complessi di coordinazione con ioni ferrosi
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
JPS6281328A (ja) * 1985-10-03 1987-04-14 Rooman Kogyo:Kk 経口持効性製剤
IT1229167B (it) * 1989-04-10 1991-07-22 Texcontor Ets Complessi del ferro o di altri metalli con derivati solfonati del chitosano
JPH0813748B2 (ja) * 1990-04-23 1996-02-14 帝國製薬株式会社 大腸崩壊性ポリペプチド系経口製剤
JP2773959B2 (ja) * 1990-07-10 1998-07-09 信越化学工業株式会社 大腸内放出性固形製剤
JP3181062B2 (ja) * 1991-01-31 2001-07-03 帝國製薬株式会社 下部消化管崩壊経口製剤
EP0576675A4 (en) * 1991-03-25 1994-06-01 Fujisawa Pharmaceutical Co Long-acting pharmaceutical preparation
JPH04327528A (ja) * 1991-04-23 1992-11-17 Lion Corp 経口用固形製剤
IT1251153B (it) * 1991-08-06 1995-05-04 Vectorpharma Int Composizioni farmaceutiche solide per somministrazione orale aventi proungata residenza gastrica
JPH06256166A (ja) * 1993-01-06 1994-09-13 ▲寛▼治 ▲高▼田 薬物放出制御製剤
NZ250844A (en) * 1993-04-07 1996-03-26 Pfizer Treatment of non-insulin dependant diabetes with peptides; composition
JP3810020B2 (ja) * 1993-04-22 2006-08-16 武田薬品工業株式会社 腎疾患の予防または治療剤
US5514670A (en) * 1993-08-13 1996-05-07 Pharmos Corporation Submicron emulsions for delivery of peptides
JP3685813B2 (ja) * 1994-03-25 2005-08-24 東光薬品工業株式会社 アロプリノール含そう剤
IL110035A0 (en) * 1994-06-16 1994-10-07 Tapuach Natural Technologies 1 Homeopathic formulations
TW401301B (en) * 1994-10-07 2000-08-11 Takeda Chemical Industries Ltd Antihypertriglyceridemic composition

Also Published As

Publication number Publication date
WO1997047323A2 (fr) 1997-12-18
EP0843559A2 (fr) 1998-05-27
CN1198100A (zh) 1998-11-04
AU3481497A (en) 1998-01-07
JPH10513202A (ja) 1998-12-15
WO1997047323A3 (fr) 1998-04-23

Similar Documents

Publication Publication Date Title
KR100818038B1 (ko) 결합된 아포리포단백질 ｅ를 가지는 단백질로 제조된 혈관-뇌 장벽 침투용 나노 입자 및 이들의 제조방법
US5258499A (en) Liposome targeting using receptor specific ligands
KR950013747B1 (ko) 폴리엔 항진균성 항생제를 캡술화한 인지질 입자의 제조 방법 및 이 인지질 입자로 이루어진 제약 조성물
EP0531497B1 (fr) Systemes de liberation orale de microparticules
KR101243689B1 (ko) 미립자 및 의약품 조성물
Chalasani et al. A novel vitamin B12-nanosphere conjugate carrier system for peroral delivery of insulin
JP5103022B2 (ja) リン酸カルシウムナノ粒子のコア、生体分子および胆汁酸を含む粒子、ならびにそれらの製造方法および治療用途
JP2886171B2 (ja) 治療薬および診断薬の内皮および上皮取り込み、および障害部位への局在化のための生物付着薬物担体
JP4524071B2 (ja) Ｓｎ−３８脂質複合体及び使用方法
US20030059465A1 (en) Stabilized nanoparticle formulations of camptotheca derivatives
EP2308473A1 (fr) Composition pharmaceutique contenant des microparticules à revêtement de surface
CN1139380A (zh) 控释制剂
US20160213788A1 (en) Active targeting antitumor drug and preparation method therefor
KR20080100376A (ko) 친수성 단백질에 기초한 활성제-농축된 나노입자
US5653999A (en) Nanoerythrosome as bioactive agent carrier
CA2228251A1 (fr) Systeme d'administration de medicaments a base de chitosan
JP2002003398A (ja) 徐放製剤、その製造法及びワクチン
JPH0436233A (ja) 生理活性物質含有生体内分解吸収性の徐放性製剤
CN116473940B (zh) 一种caf靶向的载药脂质纳米粒及其制备方法
CN112516071A (zh) 3-硼酸苯基-1-胺基甲酸胆固醇酯的注射制剂及其制备方法
CN101015698B (zh) 稀土转铁蛋白络合物作为药物载体的药物
US20210259973A1 (en) Formulations of biological polymers for oral administration
CN116496410B (zh) 一种多肽衍生物及用途
US20220168230A1 (en) Nanoparticle mediated therapy
Lepetre-Mouelhi et al. New Enkephalin Nanomedicines for Pain Alleviation, Overcoming the Side Effects of Morphine

Legal Events

Date Code Title Description
FZDE Dead